| Preface | iii |
| Table of Cases | xi |
| 1. Short title, extent and commencement | 1 |
| 2. Application of other laws not barred | 3 |
| 3. Definition | 4 |
| 4. Presumption as to poisonous substances | 14 |
| 5. The Drugs Technical Advisory Board | 15 |
| 6. The Central Drugs Laboratory | 17 |
| 7. The Drugs Consultative Committee | 20 |
| 7A. Sections 5 and 7 not to apply to Ayurvedic, Siddha or Unani drugs | 21 |
| 8. Standards of quality | 21 |
| 9. Misbranded drugs | 23 |
| 9A. Adulterated drugs | 23 |
| 9B. Spurious drugs | 24 |
| 9C. Misbranded cosmetics | 24 |
| 9D. Spurious cosmetics | 24 |
| 10. Prohibition of import of certain drugs or cosmetics | 27 |
| 10A. Power of Central Government to prohibit import of drugs and cosmetics in public interest | 28 |
| 11. Application of law relating to sea customs and powers of Customs officers | 29 |
| 12. Power of Central Government to make rules | 30 |
| 13. Offenses | 36 |
| 14. Confiscation | 37 |
| 15. Jurisdiction | 37 |
| 16. Standards of quality | 37 |
| 17. Misbranded drugs | 40 |
| 17A. Adulterated drugs | 40 |
| 17B. Spurious drugs | 41 |
| 17C. Misbranded cosmetics | 41 |
| 17D. Spurious cosmetics | 42 |
| 17E. Adulterated cosmetics | 42 |
| 18. Prohibition of manufacture and sale of certain drugs and cosmetics | 45 |
| 18A. Disclosure of the name of the manufacturer, etc | 46 |
| 18B. Maintenance of records and furnishing of information | 46 |
| 19. Please | 74 |
| 20. Government Analysts | 77 |
| 21. Inspectors | 79 |
| 22. Powers of Inspectors | 84 |
| 24. Persons bound to disclose place where drugs or cosmetics are manufactured or kept | 100 |
| 25. Reports of Government Analysts | 100 |
| 26. Purchaser of drug or cosmetic enabled to obtain test or analysis | 113 |
| 26A. Powers of Central Government to regulate, restrict or prohibit manufacture, etc., of drug and cosmetic in public interest | 113 |
| 26B. Power of Central Government to regulate or restrict,manufacture, etc., of drug in public interest | 113 |
| 27. Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter | 124 |
| 27A. Penalty for manufacture, sale, etc., of cosmetics in contravention of this Chapter | 126 |
| 28. Penalty for non-disclosure of the name of the manufacturer, etc. | 138 |
| 28A. Penalty for not keeping documents, etc., and for non-disclosure of information | 138 |
| 28B. Penalty for manufacture, etc., of drugs or cosmetics in contravention of section 26A | 139 |
| 29. Penalty for use of Government Analyst’s report for advertising | 140 |
| 30. Penalty for subsequent offences | 140 |
| 31. Confiscation | 141 |
| 31A. Application of provisions to Government departments | 142 |
| 32. Cognizance of offences | 142 |
| 32A. Power of Court to implead the manufacturer, etc. | 143 |
| 32B. Compounding of certain offences | 143 |
| 33. Power of Central Government to make rules | 152 |
| 33A. Chapter not to apply to Ayurvedic, Siddha or Unani drugs | 155 |
| 33B. Application of Chapter IVA | 155 |
| 33C. Ayurvedic and Unani Drugs Technical Advisory Board | 155 |
| 33D. The Ayurvedic, Siddha and Unani Drugs Consultative Committee | 157 |
| 33E. Misbranded drugs | 157 |
| 33EE. Adulterated drugs | 157 |
| 33EEA. Spurious drugs | 158 |
| 33EEB. Regulation of manufacture for sale of Ayurvedic, Siddha and Unani drugs | 159 |
| 33EEC. Prohibition of manufacture and sale of certain Ayurvedic,Siddha and Unani drugs | 159 |
| 33EED. Power of Central Government to prohibit manufacture, etc.,of Ayurvedic, Siddha or Unani drugs in public interest | 160 |
| 33F. Government Analysts | 160 |
| 33G. Inspectors | 160 |
| 33H. Application of provisions of sections 22, 23, 24 and 25 | 161 |
| 33-I. Penalty for manufacture, sale, etc., of Ayurvedic, Siddha or Unani drug in contravention of this Chapter | 161 |
| 33J. Penalty for subsequent offences | 162 |
| 33K. Confiscation | 163 |
| 33KA. Disclosure of name of manufacturer, etc. | 163 |
| 33KB. Maintenance of records and furnishing of information | 163 |
| 33L. Application of provisions to Government departments | 163 |
| 33M. Cognizance of offences | 164 |
| 33N. Power of Central Government to make rules | 164 |
| 33-O. Power to amend First Schedule | 165 |
| 33P. Power to give directions | 166 |
| 34. Offences by companies | 177 |
| 34A. Offences by Government departments | 178 |
| 34AA. Penalty for vexatious search or seizure | 178 |
| 35. Publication of sentences passed under this Act | 193 |
| 36. Magistrate’s power to impose enhanced penalties | 193 |
| 36A. Certain offences to be tried summarily | 194 |
| 36AB. Special Courts | 194 |
| 36AC. Offences to be cognizable and non-bailable in certain cases | 195 |
| 36AD. Application of Bharatiya Nagarik Suraksha Sanhita, 2023 [Code of Criminal Procedure, 1973] to proceedings before Special Court | 197 |
| 36AE. Appeal and revision | 196 |
| 37. Protection of action taken in good faith | 199 |
| 38. Rules to be laid before Parliament | 199 |
| The Drugs and Cosmetics Act, 1940 | 209-267 |
| The Drugs Rules, 1945 | 268-1030 |
| The Cosmetics Rules, 2020 | 1031-1100 |
| The Drugs (Prices Control) Order, 2013 | 1101-1172 |
| The New Drugs and Clinical Trials Rules, 2019 | 1173-1337 |
| The Medical Devices Rules, 2017 | 1338-1498 |
| The Dangerous Drugs Act, 1930 | 1499-1510 |
| The Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954 | 1511-1518 |
| The Drugs and Magic Remedies (Objectionable Advertisements) Rules, 1955 | 1519-1523 |
| The Drugs (Control) Act, 1950 | 1524-1527 |
| The Epidemic Diseases Act, 1897 | 1528-1531 |
| The Essential Commodities Act, 1955 | 1532-1555 |
| The Essential Commodities (Special Provisions) Act, 1981 | 1556-1560 |
| The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017 | 1561-1581 |
| The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Rules, 2018 | 1582-1587 |
| The Indian Medical Degrees Act, 1916 | 1588-1589 |
| The Indian Medical Council Act, 1956 | 1590-1614 |
| The Mental Healthcare Act, 2017 | 1615-1676 |
| The Mental Healthcare (Right of Persons with Mental Illness) Rules, 2018 | 1677-1691 |
| The Mental Healthcare (Central Mental Health Authority and Mental Health Review Boards) Rules, 2018 | 1692-1703 |
| The Mental Healthcare (State Mental Health Authority)Rules, 2018 | 1704-1712 |
| The Mental Healthcare (Central Mental Health Authority)Regulations, 2020 | 1713-1727 |
| The National Medical Commission Act, 2019 | 1728-1761 |
| The National Medical Commission, Autonomous Boards(Manner of Appointment of Fourth Member and the Salary,Allowances and Terms and Conditions of Service, and Declaration of Assets, Professional and Commercial Engagement of President and Members) Rules, 2019 | 1762-1769 |
| The National Medical Commission, Medical Advisory Council(Qualification and Experience of Residuary Members) Rules, 2019 | 1770 |
| The National Medical Commission (Submission of List of Medical Professionals) Rules, 2019 | 1771-1773 |
| The National Medical Commission (Manner of Appointment and Nomination of Members, their Salary, Allowances and Terms and Conditions of Service, and Declaration of Assets,Professional and Commercial Engagements) Rules, 2019 | 1774-1783 |
| The National Medical Commission (Annual Statement of Accounts,Submission of Annual Report and other Reports and Statements) Rules, 2019 | 1784-1819 |
| The National Commission for Indian System of Medicine Act, 2020 | 1820-1852 |
| The National Commission for Homoeopathy Act, 2020 | 1853-1883 |
| The The Institute of Teaching and Research in Ayurveda Act, 2020 | 1884-1895 |
| The National Commission for Allied and Healthcare Professions Act, 2021 | 1896-1928 |
| The Opium Act, 1878 | 1929-1934 |
| The Central Opium Rules, 1934 | 1935-1940 |
| The Pharmacy Act, 1948 | 1941-1963 |
| The Pharmacy Practice Regulations, 2015 | 1964-1990 |
| The National Institute of Pharmaceutical Education and Research Act, 1998 | 1991-2001 |
| The Cost Accounting Records (Pharmaceutical Industry) Rules, 2011 | 2002-2005 |
| The Poisons Act, 1919 | 2006-2009 |
| National Pharmaceuticals Pricing Policy, 2012 | 2010-2019 |
| National Drugs Policy on Malaria, 2013 | 2020-2026 |
| Pharmaceutical Policy, 2002 | 2027-2034 |
| National Health Research Policy of India | 2035-2045 |
| National Vaccine Policy of India, 2011 | 2046-2067 |
| National Blood Policy of India | 2068-2075 |
| National Aids Preventive & Control Policy | 2076-2095 |
| National List of Essential Medicines (NLEM) 2022 | 2096-2144 |
| Alphabetical List of Medicines in NLEM 2022 | 2145-2154 |
| Major Associations in Pharmaceuticals Industry | 2155 |
| Pharmaceutical Analytical Laboratories in India | 2156-2164 |
| Pharmaceutical Consultants in India | 2165-2174 |
| Pharmaceutical, Drug, Chemist Association-International | 2175-2181 |
| Sources of Medicinal Herbs in India | 2182-2183 |
| Manufacturers of Herbal Formulation in India | 2184 |
| Manufacturers of Herbal Cosmetics and Eucalyptus Oil in India | 2185-2186 |
| Manufacturers of Standardized Herbal Extracts,Phytochemicals and Essential Oils in India | 2187-2188 |
| List of Equipment Manufacturers in India | 2189-2190 |
| World Importers of Herbal Products | 2191-2196 |
| Words & Phrases | 2197 |
| Miscellaneous | 2200 |
LCI Learning takes pride in hosting the best and most experienced trainers in the legal field to teach their subjects inside-out, exhaustively, and with both, theory and practice.
Join us for LIVE classes, recorded courses, and free webinars as well!
Learn with us. Raise the BAR!
© 2025 LAWyersclubindia.com. Let us grow stronger by mutual exchange of knowledge.
